Team finds method to reduce accumulation of damaging Huntington's disease protein
News Apr 15, 2016
A study appearing in the journal Neuron suggests there may be a new way to change the damaging course of Huntington's disease (HD).
University of California, Irvine (UCI) neurobiologists Leslie Thompson and Joseph Ochaba with the Departments of Neurobiology & Behavior and Psychiatry & Human Behavior and their colleagues from UCI and from Children's Hospital of Philadelphia have shown that reducing the aberrant accumulation of a particular form of the mutant Huntingtin protein corresponds to improvement in symptoms and neuroinflammation in HD mice.
They showed this by targeting and modulating levels of PIAS1—a protein implicated in cancer and other diseases—which they found led to the reduction of the mutant Huntington protein.
The work suggests that changing levels of the PIAS1 protein and targeting this pathway could have a benefit to disease.
There are no current treatments for HD, although Thompson's ongoing work with stem cell-based therapies are showing promise.
Note: Material may have been edited for length and content. For further information, please contact the cited source.
Ochaba J et al. PIAS1 Regulates Mutant Huntingtin Accumulation and Huntington’s Disease-Associated Phenotypes In Vivo. Neuron, Published Online April 14 2016. doi: 10.1016/j.neuron.2016.03.016
Adult depression has long been associated with shrinkage of the hippocampus, a brain region that plays an important role in memory and response to stress. Now, new research has linked participation in team sports to larger hippocampal volumes in children and less depression in boys ages 9 to 11.
Researchers have discovered a brain process common to sleep and ageing in research that could pave the way for new treatments for insomnia. The scientists report how oxidative stress leads to sleep. Oxidative stress is also believed to be a reason why we age and a cause of degenerative diseases.READ MORE
Patients in a new Northwestern Medicine study were able to comprehend words that were written but not said aloud. They could write the names of things they saw but not verbalize them. This provides an insight into the brain degeneration that defines the rare dementia termed primary progressive aphasia.